Firetrail Investments PTY Ltd. Acquires 45,472 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Firetrail Investments PTY Ltd. lifted its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 32.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 184,942 shares of the company's stock after purchasing an additional 45,472 shares during the quarter. Ryan Specialty makes up about 3.6% of Firetrail Investments PTY Ltd.'s investment portfolio, making the stock its 14th largest position. Firetrail Investments PTY Ltd. owned 0.07% of Ryan Specialty worth $11,909,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of RYAN. Hollencrest Capital Management acquired a new position in Ryan Specialty in the third quarter worth about $25,000. Assetmark Inc. bought a new stake in shares of Ryan Specialty in the 3rd quarter valued at approximately $34,000. Principal Securities Inc. raised its holdings in shares of Ryan Specialty by 164.7% in the 4th quarter. Principal Securities Inc. now owns 667 shares of the company's stock worth $43,000 after buying an additional 415 shares in the last quarter. Quarry LP lifted its position in shares of Ryan Specialty by 109.3% during the 3rd quarter. Quarry LP now owns 808 shares of the company's stock worth $54,000 after buying an additional 422 shares during the period. Finally, Loomis Sayles & Co. L P boosted its stake in Ryan Specialty by 26.3% in the 3rd quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company's stock valued at $91,000 after buying an additional 286 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company's stock.

Remove Ads

Ryan Specialty Trading Up 1.1 %

Shares of NYSE RYAN traded up $0.79 during midday trading on Wednesday, hitting $70.77. The stock had a trading volume of 768,515 shares, compared to its average volume of 996,386. The firm has a market cap of $18.53 billion, a P/E ratio of 102.56, a price-to-earnings-growth ratio of 1.19 and a beta of 0.72. Ryan Specialty Holdings, Inc. has a fifty-two week low of $48.48 and a fifty-two week high of $75.97. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The company's 50-day simple moving average is $66.24 and its 200 day simple moving average is $67.50.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. Research analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.68%. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. The ex-dividend date is Tuesday, March 4th. Ryan Specialty's payout ratio is 69.57%.

Analysts Set New Price Targets

Several research analysts have issued reports on RYAN shares. Keefe, Bruyette & Woods dropped their price objective on Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating for the company in a research note on Friday, February 21st. Wells Fargo & Company lifted their price target on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an "equal weight" rating in a report on Friday, February 21st. UBS Group boosted their price target on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Barclays raised their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an "overweight" rating in a report on Thursday, November 21st. Finally, Morgan Stanley initiated coverage on Ryan Specialty in a report on Thursday, December 5th. They issued an "overweight" rating and a $90.00 target price on the stock. One research analyst has rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, Ryan Specialty currently has a consensus rating of "Hold" and a consensus target price of $75.27.

Insider Activity at Ryan Specialty

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 35,000 shares of the stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $66.71, for a total value of $2,334,850.00. Following the transaction, the director now owns 60,200 shares of the company's stock, valued at approximately $4,015,942. This represents a 36.76 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders have sold 316,451 shares of company stock worth $20,907,793 over the last ninety days. Company insiders own 11.10% of the company's stock.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.